Effect of hematopoietic growth factors on severity of experimental autoimmune encephalomyelitis

L. Verda, K. Luo, D. A. Kim, D. Bronesky, A. P. Kohm, S. D. Miller, L. Statkute, Y. Oyama, R. K. Burt*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


We have investigated the influence of different hematopoietic growth factors, including granulocyte colony-stimulating factor (G-CSF), stem cell factor (SCF), Flt-3 ligand (Flt-3L) and thrombopoietin (TPO), on the course of relapsing experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis. Disease course and central nervous system histology were evaluated in all groups. When given after immunization but before either disease onset or during remission, Flt-3L, SCF and G-CSF exacerbated disease severity whereas TPO had no effect compared to non-cytokine-treated controls. When compared to controls, TPO did not exacerbate disease. We conclude that autoimmune disease severity may be affected by hematopoietic growth factors currently being employed in hematopoietic stem cell transplantation of patients with autoimmune disease. The mechanism of their effects remains unknown: it may be related to both T helper (Th) 1/Th2 skewing and/or homing of inflammatory cells to the disease-affected organ.

Original languageEnglish (US)
Pages (from-to)453-460
Number of pages8
JournalBone Marrow Transplantation
Issue number6
StatePublished - Sep 2006

ASJC Scopus subject areas

  • Hematology
  • Transplantation


Dive into the research topics of 'Effect of hematopoietic growth factors on severity of experimental autoimmune encephalomyelitis'. Together they form a unique fingerprint.

Cite this